Other early signatures found in ARID1A-deficient carcinomas include the activation of the RAC (Rho family)-alpha serine/threonine-protein kinase via the increased expression of AKT1 and phosphorylation (pAKT) [49,51]. The gene discussed is AKT1; the disease is carcinoma.